Login / Signup

Peri- and Post-Menopausal Women with Schizophrenia and Related Disorders Are a Population with Specific Needs: A Narrative Review of Current Theories.

Alexandre González-RodríguezArmand GuàrdiaJosé Antonio Monreal
Published in: Journal of personalized medicine (2021)
Antipsychotic dose adjustment at menopause is recommended for schizophrenia. Raloxifene may play an important role in permitting dose reduction and lessening adverse effects. Prevention of comorbidities will help to reduce the mortality rate.
Keyphrases
  • bipolar disorder
  • cardiovascular events
  • postmenopausal women
  • cardiovascular disease
  • coronary artery disease